
Mustang Bio ( ($MBIO) ) has shared an update. On April 15, 2026, Mustang Bio received notice from Nasdaq that its common stock had closed below $1.00 for 30 consecutive
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| MBIO | Mustang Bio | 0.38 | -0.82 | -68.29% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.38 | -68.29% |

Mustang Bio ( ($MBIO) ) has shared an update. On April 15, 2026, Mustang Bio received notice from Nasdaq that its common stock had closed below $1.00 for 30 consecutive

The latest announcement is out from Mustang Bio ( ($MBIO) ). At its 2025 Annual Meeting of stockholders held virtually on December 22, 2025, Mustang Bio shareholders approved all four

An update from Mustang Bio ( ($MBIO) ) is now available. On July 7, 2025, Mustang Bio announced that the FDA granted Orphan Drug Designation for its MB-101 CAR T-cell

Mustang Bio, Sonnet BioTherapeutics, and SaverOne 2014 Ltd. are the 3 Penny Stocks to watch on July 8, 2025, based on TipRanks’ Penny Stock Screener tool. Penny stocks are defined as stocks that trade at

Mustang Bio (MBIO) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to Mustang for MB-101 for the treatment of recurrent diffuse and anaplastic astrocytoma and

Mustang Bio’s (MBIO) treatment of malignant glioma was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ultimate source for real-time,

Mustang Bio ( ($MBIO) ) has released its Q1 earnings. Here is a breakdown of the information Mustang Bio presented to its investors. Mustang Bio, Inc. is a clinical-stage biopharmaceutical

Mustang Bio (MBIO) is scheduled to report 4th quarter earnings on 03/24/2025. Regarding Q4 estimates, Wall Street analysts expect Mustang Bio to post earnings of -$5.50 per share. Last quarter,

Mustang Bio (MBIO) announced that it has received notice from Nasdaq informing the company that it has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement as required

Mustang Bio (MBIO) announced the exit of the lease for its manufacturing facility in Worcester, Massachusetts and concurrent divestment of certain fixed assets including furniture and equipment to AbbVie Bioresearch
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.